© 2023 Merck KGaA, Darmstadt, Germany and/or its affiliates. All rights reserved. EMD Serono, Inc. is the healthcare business of Merck KGaA, Darmstadt, Germany in the US and Canada.
EMD Serono is a science-led organization of curious minds dedicated to delivering transformative medicines that can make a difference in the lives of people affected by cancer.
We apply our scientific curiosity to tackling challenging tumor types in key areas—gastrointestinal (GI), genitourinary (GU), and thoracic cancers—where there are unmet needs and where we believe we can drive transformation of patient care.
By relentlessly pursuing potential solutions to even the most complex cancers, we hope to illuminate a path to scientific breakthroughs that impact patient care.
Investigational compounds are not approved by any health authority. Safety and efficacy have not been established.